Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting

Overview

Several studies have shown the beneficial effect of zinc treatment in acute diarrhea. There was a significant reduction in duration of the treated episodes and in their severity as measured by diarrheal stool output or frequency. Zinc is a potentially important immunomodulator or nutraceutical which may have great impact as therapeutic agent in conditions like diarrhea and pneumonia. The issue is whether and how zinc should be introduced in primary health care programs for treatment of acute diarrhea. A practical, sustainable intervention for introduction of zinc as treatment of acute diarrhoea in national programs is therefore required. This study aimed to address this issue.

Full Title of Study: “An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2006

Detailed Description

This cluster randomized trial aimed at evaluating in a community based controlled effectiveness trial whether addition of 2RDA zinc as a therapeutic modality to the current case management package for diarrhoea in children aged between 1 month and 5 years, delivered through existing channels at village level, resulted in reduction in care seeking from health care providers, antibiotic and other drug use and increase in ORS use rates. The intervention was being implemented in 6 PHCs; 3 intervention and 3 control. Based on the experience of a pilot study and the formative research findings, common sources visited by caregivers for care seeking during morbidity were identified. These sources were selected as channels in partnership with the local government, to distribute zinc strips and ORS packets in intervention sites and only ORS packets in control sites. These channels were physicians (at the PHC and private practitioners), the auxiliary nurse midwives (ANMs) and Anganwadi workers (AWWs) of the Integrated Child Development Services (ICDS) Scheme. All the channels were trained and supplies of zinc strips and ORS packets, and ORS packets only were distributed in each pair of PHC in intervention and control sites respectively. Recommendations were developed and translated into local vernacular. A poster, incorporating these recommendations and pictures of zinc strips and ORS packets, was designed and put up at various places in the intervention sites. For outcome measurements, cross sectional surveys were conducted at 6 monthly intervals. Process evaluation activities, which included observations of different channels and exit interviews with mothers after they had visited a channel were conducted. In the two groups, zinc was used in 36.5% and 59.8% diarrheal episodes and ORS in 34.8% and 59.2% episodes in the 4 weeks preceding interviews in intervention areas. In control areas, ORS was used in 7.8% and 9.8% episodes. Care seeking for diarrhea, prescription of drugs of unknown identity and antibiotics for diarrhea reduced in intervention communities. The study demonstrated that an intervention to improve diarrhea management with ORS and zinc is feasible and highly acceptable in rural Indian communities. The resulting health benefits were substantial and accomplished with a reduction in the cost to families for diarrhea treatment from current practices.

Interventions

  • Drug: Zinc and ORS
    • Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities
  • Drug: ORS only
    • Promoted routine management of diarrhea in underfive with ORS

Arms, Groups and Cohorts

  • Experimental: 1
    • Zinc and ORS were promoted for treatment of diarrhea in underfive children
  • Other: 2
    • Promoted routine management of diarrhea in underfive with ORS

Clinical Trial Outcome Measures

Primary Measures

  • To evaluate in a community based controlled effectiveness trial whether addition of zinc as a therapeutic modality for diarrhea delivered through existing channels, including at village level to the current case management package for under-five children
    • Time Frame: 20 months (Jan 2005 to Sep 2006)
  • – Reduction in visits to health care providers for treatment of illness
    • Time Frame: 20 months (Jan 2005 to Sep 2006)
  • – Reduction in drug use; antibiotics and other drugs during diarrheal illnesses
    • Time Frame: 20 months (Jan 2005 to Sep 2006)
  • – Increase in ORS use during diarrhea in the intervention communities.
    • Time Frame: 20 months (Jan 2005 to Sep 2006)

Secondary Measures

  • – Reduction in all cause hospitalizations
    • Time Frame: 20 months (Jan 2005 to Sep 2006)

Participating in This Clinical Trial

Inclusion Criteria

  • Children aged 1 month to 5 years with diarrhea Exclusion Criteria:

  • Illness requiring referral to hospital

Gender Eligibility: All

Minimum Age: 1 Month

Maximum Age: 5 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Society for Applied Studies
  • Collaborator
    • Ministry of Science and Technology, India
  • Provider of Information About this Clinical Study
    • Nita Bhandari, Society for Applied Studies, New Delhi
  • Overall Official(s)
    • Nita Bhandari, PhD, Principal Investigator, Society for Applied Studies

Citations Reporting on Results

Bhandari N, Mazumder S, Taneja S, Dube B, Agarwal RC, Mahalanabis D, Fontaine O, Black RE, Bhan MK. Effectiveness of zinc supplementation plus oral rehydration salts compared with oral rehydration salts alone as a treatment for acute diarrhea in a primary care setting: a cluster randomized trial. Pediatrics. 2008 May;121(5):e1279-85. doi: 10.1542/peds.2007-1939.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.